TriSalus Life Sciences (TLSI) Stock Insights

TLSI price $3.83 +0.03 +0.79%

Ticker
TLSI
Price
$3.83
Change
+0.03 +0.79%
Market cap ?
$235.83M
Beta ?
0.47
Sector
Healthcare
Industry
Medical - Devices

Fair value

TLSI fair value $5.55. Price $3.83. Price is 31% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 9.49M. Growth 17.66%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 61.57M. Net debt 14.00M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Compare TLSI

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-10—-0.14—14.02M
2026-08-06-0.16-0.1511.41M10.27M
2026-05-12-0.33-0.168.90M10.19M
2026-03-05-0.21-0.1313.21M12.82M
2025-11-13-0.96-0.1711.57M13.20M
2025-08-12-0.27-0.2211.21M11.65M
2025-05-15-0.33-0.209.17M9.09M
2025-03-27-0.35-0.358.26M8.12M
2024-11-14-0.12-0.367.35M7.38M
2024-08-14-0.21-0.497.36M6.88M
2024-05-15-0.60-0.656.46M6.17M
2024-03-12-1.34-0.695.72M5.45M
2023-11-14-0.13—5.19M—
2023-08-02-0.89—4.61M—
2023-03-31-0.31—2.98M—
2022-12-31-0.76—3.23M—
2022-11-10-0.26—3.92M—
2022-08-100.08—2.88M—
2022-05-11-0.25—2.37M—
2022-03-020.09—2.57M—
2021-12-130.06———
2021-08-160.01———
2021-06-28-0.01———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-05Cox Bryan F.Sell296$4.391.30K
2026-10-05Marshak RichardSell325$4.391.43K
2026-10-05Stevens JenniferSell316$4.391.39K
2026-10-05Szela Mary TSell2.69K$4.3811.80K
2026-07-01Patience DavidSell14.65K$4.4665.34K
2026-06-30Szela Mary TBuy3.99K$3.8715.44K
2026-06-30Marshak RichardBuy561$3.872.17K
2026-06-29Marshall Richard HenryBuy120.00K$4.74568.80K
2026-06-29Marshall Richard HenryBuy60.00K——
2026-06-29Marshall Richard HenryOther0——
2026-06-29Marshall Richard HenryOther48.00K$4.96238.08K
2026-06-29Marshall Richard HenryOther60.00K$5.55333.00K
2026-06-29Marshall Richard HenryOther25.00K$4.01100.25K
2026-05-15Marshak RichardSell543$2.671.45K
2026-05-15Wahlstrom MatsBuy60.00K$2.53151.80K
2026-05-15Stansky Michael PBuy410.00K$2.501.02M
2026-05-15Stansky Michael PBuy200.00K$2.50500.00K
2026-05-15Szela Mary TBuy39.68K$2.59102.78K
2026-05-15Patience DavidBuy7.10K$2.4317.25K
2026-05-15Gordon Gary B.Buy10.00K$2.4624.60K
2026-05-14HICKS KERRY RBuy28.20K——
2026-05-14HICKS KERRY RBuy56.40K$2.52142.14K
2026-05-14Wahlstrom MatsBuy75.20K$2.52189.51K
2026-05-14Wahlstrom MatsBuy34.23K——
2026-05-14Wahlstrom MatsBuy37.60K——
2026-05-14Gordon Gary B.Buy56.40K$2.52142.14K
2026-05-14Gordon Gary B.Buy24.55K——
2026-05-14Gordon Gary B.Buy28.20K——
2026-05-14MATLIN DAVID JBuy23.07K——
2026-05-14MATLIN DAVID JBuy28.20K——
2026-05-14MATLIN DAVID JBuy56.40K$2.52142.14K
2026-05-14Valle WilliamBuy56.40K$2.52142.14K
2026-05-14Valle WilliamBuy24.55K——
2026-05-14Valle WilliamBuy28.20K——
2026-05-14Stansky Michael PBuy20.09K——
2026-05-14Stansky Michael PBuy23.50K——
2026-05-14Stansky Michael PBuy47.00K$2.52118.45K
2026-03-17Szela Mary TSell15.94K$3.8561.38K
2026-03-16Devlin JodiSell273$4.121.12K
2026-03-16Cox Bryan F.Sell579$4.122.39K
2026-03-16Marshak RichardSell419$4.121.73K
2026-03-16Stevens JenniferSell774$4.123.19K
2026-03-12Devlin JodiSell1.77K$4.097.25K
2026-03-12Cox Bryan F.Sell1.47K$4.096.00K
2026-03-12Marshak RichardSell1.59K$4.096.50K
2026-03-12Stevens JenniferSell1.55K$4.096.35K
2026-03-11Devlin JodiSell1.16K$4.134.80K
2026-03-11Cox Bryan F.Sell1.14K$4.134.70K
2026-03-11Marshak RichardSell1.45K$4.135.98K
2026-03-11Stevens JenniferSell1.20K$4.134.97K
2026-03-11Szela Mary TSell4.36K$4.1318.00K
2026-02-23Patience DavidBuy3.66K$4.1014.99K
2026-02-23Gordon Gary B.Buy9.76K$4.1040.00K
2026-02-23Valle WilliamBuy30.49K$4.10125.00K
2026-02-23Szela Mary TBuy30.49K$4.10125.00K
2026-02-23Stansky Michael PBuy243.90K$4.10999.99K
2026-02-23Stansky Michael PBuy117.20K$4.10480.51K
2026-02-04Stansky Michael PBuy92.54K$4.91454.36K
2026-02-04Stansky Michael POther0——
2026-02-04Stansky Michael POther0——
2025-12-31Szela Mary TBuy2.10K$4.389.20K
2025-12-31Szela Mary TOther0——
2025-12-31Marshak RichardBuy449$4.381.97K
2025-12-31Marshak RichardOther0——
2025-11-24Cox Bryan F.Buy80.00K$5.55444.00K
2025-11-24Cox Bryan F.Buy40.00K——
2025-11-24Devlin JodiBuy100.00K$5.55555.00K
2025-11-24Devlin JodiBuy50.00K——
2025-11-24Szela Mary TBuy250.00K$5.551.39M
2025-11-24Szela Mary TBuy300.00K——
2025-11-24Szela Mary TBuy125.00K——
2025-11-24Stevens JenniferBuy100.00K$5.55555.00K
2025-11-24Stevens JenniferBuy50.00K——
2025-11-24Marshak RichardBuy120.00K$5.55666.00K
2025-11-24Marshak RichardBuy60.00K——
2025-11-24Patience DavidBuy130.00K$5.55721.50K
2025-11-24Patience DavidBuy65.00K——
2025-08-28Patience DavidBuy248.90K$5.111.27M
2025-08-14Patience DavidBuy290.00K$3.881.13M
2025-08-14Patience DavidBuy200.00K——
2025-07-31Frankenius Equity ABBuy759.00K——
2025-07-31Frankenius Equity ABSell230.00K$4.00920.00K
2025-07-31MATLIN DAVID JBuy330.00K——
2025-07-31MATLIN DAVID JSell100.00K$4.00400.00K
2025-07-01Patience DavidOther0——
2025-06-30Szela Mary TBuy2.85K$4.2312.05K
2025-06-30Marshak RichardBuy930$4.233.93K
2025-06-12Desai Arjun JJBuy15.00K$5.5082.50K
2025-06-12Gordon Gary B.Buy15.00K$5.5082.50K
2025-06-12HICKS KERRY RBuy15.00K$5.5082.50K
2025-06-12MATLIN DAVID JBuy15.00K$5.5082.50K
2025-06-12Murphy SeanBuy15.00K$5.5082.50K
2025-06-12Valle WilliamBuy15.00K$5.5082.50K
2025-06-12Wahlstrom MatsBuy15.00K$5.5082.50K
2025-05-19Young James EmmettBuy13.18K$5.1868.25K
2025-05-19Cox Bryan F.Buy15.72K$5.1881.44K
2025-05-19Cox Bryan F.Sell4.76K$5.1824.68K
2025-05-19Devlin JodiBuy24.13K$5.18125.00K
2025-05-19Devlin JodiSell4.76K$5.1824.68K
2025-05-19Marshak RichardBuy21.43K$5.18111.00K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 81, holders -4 vs prior quarter. Ownership 37.52%.

HolderSharesChangeChange %Value
FIRST LIGHT ASSET MANAGEMENT, LLC6.55M1.49M+29.32%29.81M
BLACKROCK, INC.2.66M1.16M+77.33%12.10M
VANGUARD CAPITAL MANAGEMENT LLC1.73M382.35K+28.38%7.87M
CERITY PARTNERS LLC1.60M816.27K+103.68%7.30M
GEODE CAPITAL MANAGEMENT, LLC1.19M412.97K+53.14%5.42M
NANTAHALA CAPITAL MANAGEMENT, LLC1.00M-1.07M-51.71%4.55M
GILDER GAGNON HOWE & CO LLC850.08K-38.43K-4.33%3.87M
STATE STREET CORP610.96K282.94K+86.26%2.78M
WHITE PINE CAPITAL LLC547.58K347.73K+174.00%2.49M
THOMPSON SIEGEL & WALMSLEY LLC536.53K-47.04K-8.06%2.44M
KENNEDY CAPITAL MANAGEMENT LLC476.26K-8.98K-1.85%2.17M
MORGAN STANLEY401.81K7.91K+2.01%1.83M
NORTHERN TRUST CORP379.57K158.10K+71.39%1.73M
VANGUARD PORTFOLIO MANAGEMENT LLC329.46K164.61K+99.85%1.50M
VANGUARD FIDUCIARY TRUST CO320.96K102.60K+46.99%1.46M
LIONHUNTER CAPITAL MANAGEMENT, LLC300.27K300.27KNew1.37M
PERKINS CAPITAL MANAGEMENT INC235.10K5.00K+2.17%1.07M
UBS GROUP AG223.05K143.50K+180.38%1.01M
BANK OF AMERICA CORP /DE/205.34K3.62K+1.80%934.31K
ROYCE & ASSOCIATES LP200.06K00.00%910.27K
CORIENT PRIVATE WEALTH LP147.15K56.15K+61.71%669.54K
AQR CAPITAL MANAGEMENT LLC117.98K117.98KNew536.80K
BANK OF NEW YORK MELLON CORP111.53K45.73K+69.49%507.48K
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.107.94K107.94KNew491.15K
CHARLES SCHWAB INVESTMENT MANAGEMENT INC107.94K23.81K+28.30%491.15K

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

TriSalus Life Sciences (TLSI) Stock Insights

TLSI$3.83+0.03 +0.79%

$235.83M

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History